Paul has 34 years of experience in the pharmaceutical and biotech industry, and has worked in preclinical microbiology, anti-infective and oncology clinical research, project management, and managed a Phase I Research Clinic. Prior to joining Amplyx, Paul held positions at Warner-Lambert/Parke-Davis, DepoTech, Agouron, Pfizer, Trius Therapeutics, and Progenity. While at Pfizer he served as a Research Team Leader and Exploratory Development Director leading several oncology drug development teams. He has been involved in a number of successful drug development programs including Penetrex®, Sparfloxacin®, Cefzon®, Viracept®, Sutent®, Inlyta®, and Sivextro®. Paul received his B.S. in Microbiology and Public Health from Michigan State University and his M.S. from the University of Michigan in Clinical Trial Design and Statistical Analysis.